Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells
- PMID: 21367910
- PMCID: PMC3126162
- DOI: 10.1128/JVI.00284-11
Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells
Abstract
Despite successful antiretroviral therapy (ART), low-level viremia (LLV) may be intermittently detected in most HIV-infected patients. Longitudinal blood plasma and resting CD4(+) T cells were obtained from two patients on suppressive ART to investigate the source of LLV. Single-genome sequencing of HIV-1 env from LLV plasma was performed, and the sequences were compared to sequences recovered from limiting-dilution outgrowth assays of resting CD4(+) T cells. The circulating LLV virus clone was identical to virus recovered from outgrowth assays from pools of millions of resting CD4(+) T cells. Understanding the sources of LLV requires evaluation of all possible reservoirs of persistent HIV infection.
Figures


Similar articles
-
Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells.J Med Virol. 2009 Jan;81(1):9-15. doi: 10.1002/jmv.21366. J Med Virol. 2009. PMID: 19031450 Free PMC article.
-
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.J Virol. 2006 Jul;80(13):6441-57. doi: 10.1128/JVI.00591-06. J Virol. 2006. PMID: 16775332 Free PMC article.
-
Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.J Virol. 2009 Sep;83(17):8470-81. doi: 10.1128/JVI.02568-08. Epub 2009 Jun 17. J Virol. 2009. PMID: 19535437 Free PMC article.
-
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.Retrovirology. 2018 Jan 30;15(1):15. doi: 10.1186/s12977-018-0398-1. Retrovirology. 2018. PMID: 29378611 Free PMC article. Review.
-
The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.Retrovirology. 2017 Nov 21;14(1):52. doi: 10.1186/s12977-017-0376-z. Retrovirology. 2017. PMID: 29157283 Free PMC article. Review.
Cited by
-
Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy.J Clin Microbiol. 2012 Feb;50(2):258-63. doi: 10.1128/JCM.06022-11. Epub 2011 Nov 30. J Clin Microbiol. 2012. PMID: 22135262 Free PMC article.
-
Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.J Virol. 2020 Jan 17;94(3):e01270-19. doi: 10.1128/JVI.01270-19. Print 2020 Jan 17. J Virol. 2020. PMID: 31723024 Free PMC article.
-
New Frontiers in Measuring and Characterizing the HIV Reservoir.Front Microbiol. 2019 Dec 18;10:2878. doi: 10.3389/fmicb.2019.02878. eCollection 2019. Front Microbiol. 2019. PMID: 31921056 Free PMC article. Review.
-
Persistent HIV-1 replication maintains the tissue reservoir during therapy.Nature. 2016 Feb 4;530(7588):51-56. doi: 10.1038/nature16933. Epub 2016 Jan 27. Nature. 2016. PMID: 26814962 Free PMC article.
-
HIV antibodies for treatment of HIV infection.Immunol Rev. 2017 Jan;275(1):313-323. doi: 10.1111/imr.12506. Immunol Rev. 2017. PMID: 28133794 Free PMC article. Review.
References
-
- Blankson J. N., Persaud D., Siliciano R. F. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557–593 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
- R01 AI064074/AI/NIAID NIH HHS/United States
- R56 AI044667/AI/NIAID NIH HHS/United States
- R01 AI045297/AI/NIAID NIH HHS/United States
- AI45297/AI/NIAID NIH HHS/United States
- AI44667/AI/NIAID NIH HHS/United States
- R56 AI045297/AI/NIAID NIH HHS/United States
- RR025747/RR/NCRR NIH HHS/United States
- UL1 RR025747/RR/NCRR NIH HHS/United States
- R01 AI044667/AI/NIAID NIH HHS/United States
- AI50410/AI/NIAID NIH HHS/United States
- P30 AI050410/AI/NIAID NIH HHS/United States
- R37 AI044667/AI/NIAID NIH HHS/United States
- AI064074/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials